Evidence map›Paper›PMID 26339383›Full record

ArticleInternational journal of clinical and experimental pathology2015

Comparison of structural genetics of non-schistosoma-associated squamous cell carcinoma of the urinary bladder.

Marina Molitor, Kerstin Junker, Elke Eltze, Marieta Toma, Stefan Denzinger, Sabine Siegert, Ruth Knuechel, Nadine T Gaisa

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Genomic Subtyping in Bladder Cancer.Current urology reports · 2020
    Review
  9. Review
  10. Diagnostic and Prognostic Implications of FGFR3International journal of molecular sciences · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Marina MolitorInstitute of Pathology, RWTH Aachen University Aachen, Germany.
Kerstin JunkerDepartment of Urology, Friedrich-Schiller-University Jena, Germany ; Department of Urology, Saarland University Homburg, Germany.
Elke EltzeInstitute of Pathology Saarbruecken-Rastpfuhl Saarbruecken, Germany.
Marieta TomaInstitute of Pathology, University Dresden Dresden, Germany.
Stefan DenzingerDepartment of Urology, University Hospital Regensburg Regensburg, Germany.
Sabine SiegertInstitute of Pathology LMU Munich Munich, Germany ; Institute of Pathology Munich-Nord Munich, Germany.
Ruth KnuechelInstitute of Pathology, RWTH Aachen University Aachen, Germany.
Nadine T GaisaInstitute of Pathology, RWTH Aachen University Aachen, Germany.
RWTH Aachen University · DEFriedrich Schiller University Jena · DEHochschule für Technik und Wirtschaft Dresden – University of Applied Sciences · DELMU Klinikum · DEMax Planck Institute for Informatics · DEUniversity Hospital Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Little is known about genetic changes in squamous differentiation of non-schistosomiasis-associated bladder cancer. Therefore, we investigated pure squamous cell carcinomas (SqCC), squamous parts of mixed urothelial carcinomas with squamous differentiation (MIX) and mere urothelial cancers (UC) for structural genetic differences. Tissue microarray slides (n = 29 SqCC, n = 35 MIX and n = 23 UC) were analyzed by ZytoLight SPEC p16/CEN3/7/17 Quadruple Color Probe fluorescence-in-situ-hybridization (FISH) and DNA was investigated by comparative genomic hybridization (CGH) (n = 35 SqCCs, n = 40 MIX and n = 36 UC). By FISH the mean number of polysomic cells was lowest in SqCC (CEN3 P = 0.0498, CEN17 P = 0.0009). A slight tendency of lower copy numbers of chromosomes 3, 7 and 17 and higher numbers of the p16-locus in SqCC (P = 0.45) indicated less aneuploid tumor cells in SqCC compared to MIX and UC. In CGH SqCC showed the lowest mean number of aberrations per tumor (SqCC 5.37 changes, MIX 6.75 and UC 7.64; P = 0.1754). Significant differences between the three groups were found for loss of chromosome 3p (P = 0.004), 6q (P = 0.028), 11p (P = 0.024) and gains of 5p (P = 0.020). Loss of 3p was more frequent in SqCC (51.4%) than in MIX (37.5%) or UC (13.9%). To conclude, SqCCs show less polysomy and genetic alterations than MIX and UC. Loss of 3p is more frequent in SqCC but there are no absolute specific alterations for each tumor group. Squamous parts of mixed tumors show similar alterations than UC and should be considered as further development of UC, while pure SqCC seem to be a separate tumor group.

Indexed as

Chromosomes, HumanAdultAgedAged, 80 and overBiomarkers, TumorCarcinoma, Squamous CellChromosome AberrationsComparative Genomic HybridizationFemaleGene Expression Regulation, NeoplasticGenetic Predisposition to DiseaseGermanyHumansIn Situ Hybridization, FluorescenceMaleMiddle AgedBiomarkers, TumorBladder cancerCGHFISHsquamous cell carcinomaurothelial carcinomaurothelial carcinoma with squamous differentiation

Identifiers

PMID26339383
PMCPMC4555711
OpenAlexW2464087748

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.